NICOLINI, SILVIA
NICOLINI, SILVIA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.007 secondi).
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
2022 Bongiovanni, Alberto; Nicolini, Silvia; Ibrahim, Toni; Foca, Flavia; Sansovini, Maddalena; Di Paolo, Arianna; Grassi, Ilaria; Liverani, Chiara; Calabrese, Chiara; Ranallo, Nicoletta; Matteucci, Federica; Paganelli, Giovanni; Severi, Stefano
Circulating androgen receptor (AR) gene amplification and resistance to 177Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of a phase II clinical trial
2019 De Giorgi, U; Severi, S; Sarnelli, A; Sansovini, M; Monti, M; Gurioli, G; Nicolini, S; Scarpi, E; Casadei, C; Conteduca, V; Matteucci, F; Di Iorio, V; Amadori, D; Paganelli, G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials | Bongiovanni, Alberto; Nicolini, Silvia; Ibrahim, Toni; Foca, Flavia; Sansovini, Maddalena; Di Pao...lo, Arianna; Grassi, Ilaria; Liverani, Chiara; Calabrese, Chiara; Ranallo, Nicoletta; Matteucci, Federica; Paganelli, Giovanni; Severi, Stefano | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-06022.pdf; cancers-14-06022-s001.zip |
| Circulating androgen receptor (AR) gene amplification and resistance to 177Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of a phase II clinical trial | De Giorgi, U; Severi, S; Sarnelli, A; Sansovini, M; Monti, M; Gurioli, G; Nicolini, S; Scarpi, E;... Casadei, C; Conteduca, V; Matteucci, F; Di Iorio, V; Amadori, D; Paganelli, G | 2019-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |